Found predominantly in African Americans.

Neither of the parties endorse or suggest any commercial products, services, or equipment. Alcon will roll out the drug in Finland and Norway shortly. US sales since launch are good Company's expectations. We look forward to further launches over the Nordic region and additional countries to make sure that patients can get access to the first pharmacological treatment for VMT including when connected with a macular hole of size less than or equal to 400 microns.